The pharmaceutical industry is witnessing a significant shift in glucose treatment with the introduction of GLP-1 patches. These groundbreaking vehicles offer a likely simple choice to injections for individuals living with diabetes mellitus type 2. By bypassing the necessity for frequent injections, GLP-1 patches promise to boost user adherence an